Sticking - Capping - Lamination

Sticking - Capping - Lamination

Berlin, Germany

Course No 15387


Costs

This conference already took place.

If you have any questions, please contact us:
Tel.: +49 (0)6221 / 84 44 0 E-Mail: info@gmp-compliance.org

Speakers

Dr Michael Braun, Boehringer Ingelheim Pharma

Dr Harald Stahl, GEA Pharma Systems

Prof Dr Paul WS Heng, University of Singapore

Objectives

This course aims at explaining were problems in the tableting process come from and how these issues can be avoided or solved. This includes optimisation and trouble-shooting during:

  • The development phase
  • The scale-up and transfer phase
  • The routine and full-scale production

Background

Tableting ranks among the most important pharmaceutical manufacturing processes. Representing about 50% of the total pharmaceutical market, tablets have a particular position. Yet, although tableting is wide spread and used since the invention of the stamp/matrix principle in 1843, there are still open questions and problems in the daily routine which often appear during scale-up or transfer from development. Also in the daily routine with validated processes, issues may arise like for example tablets which suddenly start capping or sticking, or tablets with decreasing hardness or with fluctuations of the content.

Many of these problems originate from the development phase of the tablet and only become visible after transfer to the commercial plant, were usually much bigger and faster presses are used.

The development process should be a holistic approach which takes into account the requirements of a high speed rotary tablet press on its feed materials. The definition of critical process parameters, the selection of excipients based on the mechanical compatibility of API/excipient and the formulation itself must be seen in the full context.

But even after a transfer to the commercial plant, there are some possibilities to get rid off tableting problems, besides lowering the speed of compression. Using coatings, special matrices and stamps or changing the relative humidity or tempering of the tablet press are some amongst others, we are going to talk about. Also the optimisation of upstream processes such as granulation often allows a significant improvement of the subsequent tableting process.

Target Group

This event is designated for all professionals from Pharmaceutical Development and Production, who are responsible for the development, the routine production or the scale-up and transfer of tableting processes.

Programme

Development & Formulation

Mechanical compatibility of excipients and APIs
  • Basics on the deformation and cohesion in tablets
  • Determination of the deformation characteristics using compression analysis
  • Explanation of the most relevant excipients
  • Classification of excipients in deformation classes
  • Finding the right API and excipient combination
  • Case studies
Development of a tablet formulation for production
In this presentation, the development of an early formulation will be discussed with reference to critical parameters. Such parameters include API load and excipients incorporated together with tablet product characteristics, in particular, hardness and disintegration. Usually, in product development, equipment available in the development department often differs from the equipment used at production-scale.
A discussion on the pitfalls of trying to scale-up a laboratory formulation will be presented in this course.

Prerequisites for successful tableting


Essentials for successful tableting
  • Mechanism of compaction
  • Compaction behavior of pharmaceutical materials
  • Granulation
  • Mechanisms of agglomeration
  • The different granulation types and their influence on the granules’ characteristics
  • Influence of liquid and energy input, geometry of equipment etc. on the compressibility
  • The compression cycle
Tablet presses in production scale
  • Why formulations from development often make problems
  • Modern instrumentation of tablet presses
  • The differences of ‘old’ and ‘new’ presses
  • Effects of changing the filling time, compression time, circulation speed…
  • The influence of tooling

Transfer and Scale-Up


Theory
In this presentation the developed formulation is given to production. Will it work?

Scale-up and transfer from development to production: The Real World
In this session a systematic approach, following QbD principles for scale-up and transfer from development to production will be presented. Case studies focusing on the scale-up of the compression step will illustrate how this can be realized in practice and further look into technical issues and solutions
  • Identification and evaluation of Critical Process Parameters and Critical Attributes and link to Drug Product Quality Attributes
  • Scale-up principles and transfer strategy
  • Case studies

Debugging – make it work


Re-formulation
In this presentation, the initial formulation is re-designed by using the knowledge gained through the presentation. Revealing of parameters which should have been defined earlier:
  • Critical quality attributes
  • Critical process parameters
  • Linkage of CQAs and CPPs for the example formulation
Trouble-Shooting
In this interactive session, all the key elements of the preceding lectures are brought together. A systematic approach is presented and discussed with regards to the extent, trouble shooting measures have to be escalated: what can be done on the operator level, what can be done on the supervisor level, what must be done by development:
  • Reasons for capping and what to do
  • Reasons for sticking and what to do
  • Reasons for lamination and what to do
  • Reasons for variations in weight and what to do
  • Reasons for failing in hardness and what to do
  • Reasons for failing in disintegration and what to do

Go back

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK